A new ruling to stop some Apple Watch imports could help medtech company Masimo reach a settlement with the $2.7 trillion tech giant after a years-long patent battle.he International Trade Commission issued an order to halt the importation of certain Apple Watches into the United States last week, handing a major win to medical device-maker Masimo in a years-long patent battle with the most valuable company in the world.
The import ban is now subject to a 60-day presidential review and, barring intervention by the Biden Administration, is slated to go into effect on December 25. Apple said it plans to appeal the decision, which does not immediately affect Apple Watch sales.he hopes the ITC decision “might speed things up” and push Apple towards a settlement agreement with its $4.2 billion market cap challenger. But he said he won’t accept a check for a licensing deal from the $2.
But unless Apple can convince the Biden administration to veto the ruling in the next two months, the ban would go into effect while the appeals process plays out in federal court. “Masimo has wrongly attempted to use the ITC to keep a potentially lifesaving product from millions of U.S. consumers while making way for their own watch that copies Apple,” spokesperson Fred Sainz said in a statement.
The case gets to the heart of a bigger strategic question for Apple: Does the company want to sell regulated healthcare products or stick with consumer products? Kiani said he would also be “fine” with Apple instituting a redesign, rather than a settlement agreement. “Not everything is about financial gain,” he said. He quickly clarified, however, that his company would still pursue a financial settlement in federal court to recoup Masimo’s losses for past infringement.
Technology Technology Latest News, Technology Technology Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: dcexaminer - 🏆 6. / 94 Read more »